We have completed another exciting year of operation. The BioPontis Alliance 2017 Annual Report documents our progress in treatment development and our significant steps forward in our mission. Click here to read the report.
BioPontis Alliance for Rare Diseases is an international nonprofit organization whose mission is to advance promising science into potential treatments for rare neurological diseases. We meet our mission by involving patients in the development of their own treatments, through alliances with patients organizations worldwide.
BioPontis Alliance for Rare Diseases is dedicated to the development of new therapeutic agents to treat rare diseases. The niche philanthropy uses a collaborative approach, partnering with patient organizations and academic researchers. BioPontis provides the plans and executes the preclinical translational scientific, early clinical development, patenting, and business relationship management. We bring the expertise that is needed to advance ideas for treatments into drug compounds that are ready for uptake by the biopharmaceutical and biotech industry.